STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes?

This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up but we expect to drop in at a couple of folkie happenings, promenade with the official mascots, and tidy up around the castle.

We also hope to have yet another listening party, where the rotation will likely include this , this , this , this and this . And what about you?

This is a fine time to enjoy the great outdoors. Hiking trials, shorelines, and cityscapes await you.

This may also be an opportunity to start your spring cleaning, read a good book, or search out someone special. Well, whatever you do, have a grand time.

But be safe. Enjoy, and see you soon.

… President Trump heralded a drug-pricing agreement with Regeneron Pharmaceuticals, closing the last of 17 deals initially sought by the White House last year , STAT notes.